創傷洗浄剤市場- 世界および地域別分析：製品タイプ別、創傷別、エンドユーザー別、国別 - 分析と予測（2025年～2035年）

創傷洗浄剤市場は、効果的な創傷ケアソリューションに対する需要の高まりにより、ヘルスケア業界で急成長している分野です。

創傷洗浄剤は、創傷の洗浄と灌流を目的とした特殊なソリューションであり、創傷ケア管理において重要な役割を果たしています。創傷洗浄剤市場には、創傷から残渣、細菌、汚染物質を除去し、最適な治癒と感染予防を確実にするために処方された幅広い製品が含まれます。これらの製品は、ドレッシング材の適用、縫合、その他の治療介入など、その後の治療に備えて創傷を準備するのに不可欠であり、創傷洗浄剤市場を現代のヘルスケアに欠かせない要素にしています。

創傷洗浄剤市場の拡大に拍車をかけている要因はいくつかありますが、慢性疾患の有病率の上昇が創傷ケア製品の需要増につながっています。外科手術や外傷症例の増加が創傷洗浄ソリューションの必要性をさらに高め、創傷洗浄剤市場全体の成長に寄与しています。さらに、創傷感染症の増加により、効果的な創傷洗浄の重要性が強調され、創傷洗浄剤市場の技術革新と進歩が促進されています。

創傷洗浄剤市場の拡大に寄与するもう1つの重要な要因は、高度な創傷ケア製品の受け入れと採用が増加していることです。創傷ケア専門クリニックの増加と医療技術の進歩により、臨床と在宅ケアの両方で創傷洗浄剤の認知度と利用度が高まっています。創傷洗浄剤市場は進化を続けており、メーカー各社は治癒効果を高め、患者ケアを向上させ、より効率的で革新的な創傷洗浄ソリューションの開発に注力しています。創傷ケア製品への需要が高まり続けていることから、創傷洗浄剤市場は今後数年で大きく成長する見込みです。

影響分析

創傷洗浄剤市場は、以下のような影響を及ぼしています：

• 創傷ケアの実践強化：高度な創傷洗浄剤の導入により、創傷ケアの実践が大幅に改善されました。これらの洗浄剤は、創傷の洗浄、感染リスクの最小化、治癒プロセスの促進により効果的なソリューションを提供します。
• 感染率の低下：抗菌作用のある創傷洗浄剤は、ヘルスケア環境全体における感染率の低下に重要な役割を果たしています。これらの製品は、創傷における細菌や病原菌の繁殖を防ぎ、合併症の可能性を低減します。
• 治癒の促進：創傷洗浄剤の処方の革新は、治癒時間の短縮につながりました。創傷の残骸や壊死組織を効率的に除去することで、創傷の修復に集中できるようになります。
• 患者の快適性の向上：優しく効果的な創傷洗浄剤の開発により、治療中の患者の快適性が向上しました。洗浄時の痛みや刺激が軽減されることで、処方されたケアレジメンの遵守率が向上します。
• ヘルスケアにおけるコスト削減：合併症を予防し、治癒を早めることで、創傷洗浄剤はヘルスケアコストの削減に貢献します。感染率の低下や入院期間の短縮は、患者にとってもヘルスケアシステムにとっても経済的な節約となります。
• アクセシビリティの向上：創傷洗浄剤技術の進歩により、病院、クリニック、在宅ケア環境など、幅広いヘルスケア施設での利用が可能になりました。これにより、患者は場所を問わず質の高い創傷ケアを受けることができます。
• 最先端技術の統合：創傷洗浄剤市場には、治癒の進行をモニターしたり自動投与を行うスマート創傷洗浄剤などの新技術が組み込まれています。こうした技術革新により、より個別化された効果的な創傷ケア戦略が可能になります。
• 継続的な研究開発：創傷洗浄剤市場の継続的な成長により、研究開発への投資が増加しています。これには、患者の転帰を一貫して改善するための新規成分、製剤、投与方法の探求が含まれます。

市販の創傷洗浄剤は、創傷を効果的に洗浄し、最適な治癒環境を作り出すよう設計された標的処方により、創傷ケア市場を独占すると予想されます。様々な形状で提供され、特定の創傷ケアニーズに合わせて調整されるこれらの洗浄剤には、一般的に有効成分が含まれており、治癒プロセスを促進しながら、残渣、細菌、汚染物質の除去を助けます。その特殊性と様々なタイプの創傷を管理する有効性から、ヘルスケアプロバイダーと患者の両方にとって好ましい選択肢となっており、市場の継続的な優位性を牽引しています。

生理食塩水による創傷洗浄剤は、その簡便性、安全性、穏やかな作用が主な理由で、最も速い速度で成長すると予測されています。生理食塩水は、精製水に塩化ナトリウムを溶かした滅菌溶液で構成され、体内の自然な体液に近いため、創傷の灌流や洗浄に理想的で刺激の少ない選択肢となります。臨床現場と在宅ケアの両方で広く使用されており、低コストで合併症のリスクも少ないことから、生理食塩水洗浄剤は創傷ケア市場で急成長している分野です。

慢性創傷は、自然治癒プロセスの障害によって生じる複雑で長期にわたる傷害であり、多くの場合、糖尿病などの基礎疾患によるものです。褥瘡、糖尿病性足潰瘍、静脈性下腿潰瘍などのこれらの創傷は治癒が困難で、数カ月から数年にわたり持続することもあります。糖尿病患者の約15～25％が慢性創傷を発症するリスクがあります。その持続的な性質と慢性疾患の有病率の上昇により、慢性創傷は創傷洗浄剤市場を独占すると予想されます。感染症に効果的に対処し、治癒を促進し、合併症を管理する専門的な創傷ケア製品へのニーズが、この分野の持続的な需要の原動力となっています。

急性創傷は4～6週間以内に予測通りに治癒するもので、一般的に外傷や傷害に起因します。このような創傷は明確な治癒の軌跡をたどりますが、特に事故や手術、スポーツ関連の負傷が多い先進地域では、世界の発生率が増加傾向にあります。急性創傷の症例数が増加するにつれて、これらの傷害を管理するための効果的な創傷洗浄剤に対する需要は急速に高まると思われます。急性創傷治療分野は、回復に要する時間が短く量が多いこと、感染症などの合併症を予防するために適切な創傷管理に対する意識が高まっていることから、最も速い速度で成長すると予測されます。

病院分野は、急性創傷と慢性創傷の両方の治療において大きなシェアを占めているため、創傷洗浄剤市場をリードしています。病院は、外科的創傷、熱傷、外傷関連傷害などの複雑な症例を管理する能力があるため、需要の主要な牽引役となっており、これらすべてにおいて専門的な創傷洗浄ソリューションが必要とされます。さらに、病院には高度な医療資源が備わっているため、創傷ケアの重要な拠点となっています。

在宅ケア分野は市場で最も急成長しています。特に糖尿病性潰瘍や褥瘡のような慢性疾患では、自宅での創傷管理が好まれるようになっていることが成長の原動力となっています。セルフケアに対する消費者の意識の高まりと、先進的な市販創傷ケア製品の利便性と入手可能性が、創傷洗浄剤市場におけるホームケア分野の急拡大を後押ししています。

北米が2024年に最大の市場シェアを占めたのは、その先進的なヘルスケアインフラ、強力な経済支援、慢性創傷の発生率増加の一因となる糖尿病や肥満などの慢性疾患の有病率の上昇によるものです。米国では、3M Tegaderm Wound Cleanserなどの製品を提供する3Mや、Medline Remedy Phytoplex Skin &Wound Cleanserを提供するMedlineなどの大手メーカーが創傷洗浄剤の需要を後押ししています。これらの製品は、感染予防や早期治癒を促進する効果があるため、病院や在宅介護の現場で広く使われています。また、北米では高齢化が進んでおり、600万人以上の米国人が慢性創傷、特に褥瘡や糖尿病性足潰瘍に苦しんでいることから、創傷ケア製品のニーズが高まっています。この人口動態の変化は、創傷ケア製品への幅広いアクセスを保証する包括的なヘルスケア政策に支えられており、創傷洗浄剤市場の成長を促進しています。

2024年のアジア太平洋地域の創傷洗浄剤市場は中国がリードしています。この成長の主な原動力には、創傷回復製品に対する需要の増加、慢性創傷の有病率の上昇、地域全体での外科手術件数の増加などがあります。この需要に寄与している顕著な要因は、中国における糖尿病の高い有病率であり、糖尿病患者の治癒遅延に対処する創傷ケアソリューションの必要性が高まっています。足潰瘍は糖尿病患者によく見られる衰弱させる合併症で、脚の切断など深刻な結果につながることも多いです。国際糖尿病連合（IDF）によると、2021年の中国の糖尿病患者数は1億4,090万人で、人口の10.6%を占めています。この数は2030年までに1億6,406万人に増加すると予測されており、2021年の未診断患者数は7,283万人と推定されています。糖尿病の罹患率の高さは、特に糖尿病性足潰瘍に関連した、糖尿病性フットケア管理および創傷ケア製品に対する需要の増加に直結しています。

創傷洗浄剤市場の最近の動向

• 2023年4月、Sanara MedTech Inc.は、Biacos技術を活用した特許製剤であるBiasurge高度外科用溶液の510（k）認可を取得したと発表しました。Biasurgeは機械的洗浄と創傷からの微生物を含む残屑の除去のために設計されています。
• 2023年1月、Sonoma Pharmaceuticals, Inc.は、国防兵站局（DLA）からMicrocyn Rx製品の販売と価格に関する合意を得たことを明らかにしました。この契約により、DLAのネットワークを通じてMicrocyn Rx製品を販売できるようになり、同社にとって重要なマイルストーンとなります。
• 2021年11月、Sonoma Pharmaceuticals, Inc.とDyamed Biotech Pte Ltd.は、シンガポール、マレーシア、インドネシア、タイ市場に焦点を当てた長期的パートナーシップを拡大しました。この提携は、ソノマのMicrocyn技術を活用し、患者とヘルスケアプロバイダーの双方に利益をもたらすことを目的としています。
• 2021年3月、Sonoma Pharmaceuticals, Inc. はEMC Pharma, LLCと、HOClをベースとしたSonomaの処方皮膚科・眼科用製品を米国で監督・販売促進・流通させる契約を締結しました。
• 2022年11月、InfuSystem Holdings, Inc.とSanara MedTech Inc.はSI Wound Care, LLCのパートナーシップを締結しました。このパートナーシップにより、InfuSystemはCork Medical LLCの陰圧創傷治療器やSanaraの高度創傷ケアソリューションなどの革新的な製品を新しい顧客に紹介することができます。
• 2023年6月、Armis Biopharmaの医療機器VeriCyn Wound WashがFDAから510（k）認可を受け、創傷の付着物の洗浄に使用できるようになっています。
• 2023年4月、Convatecは英国の30 Technologyから技術を取得し、この技術がConvatecの既存の製品ポートフォリオにいつどのように統合されるかという憶測を呼びました。
• 2023年2月、Shore Capital PartnersがArgentum MedicalをBioDermに売却しました。
• 2023年5月、NovaBay Pharmaceuticals, Inc.は、China Pioneer Pharma Holdings, LimitedがNovaBayのNeutroPhase Skin and Wound Cleanserを100万米ドルで発注したと発表しました。ノバベイは注文の履行を完了し、2023年第2四半期に関連収益を認識する予定です。
• 2019年5月、Smith & Nephewは創傷治療、整形外科、スポーツ医学向けの再生医療製品の開発と普及を専門とするOsiris Therapeutics, Inc.を買収しました。

市場需要促進要因：

創傷洗浄剤の利用増加を促進する慢性疾患の有病率の上昇：世界の慢性疾患の増加は、今や世界全体の死亡原因の63%を占めており、創傷感染症の増加に大きく寄与しています。米国では1億3,300万人以上が慢性疾患に罹患しており、これは人口の40％以上を占めています。このような慢性疾患の急増は創傷洗浄剤の需要に直接影響しており、慢性創傷の管理は患者の転帰を改善する上で不可欠となっています。

外科手術と外傷の急増が創傷洗浄剤の需要を拡大：ヘルスケアへのアクセス向上と急速な高齢化により、年間手術件数は大幅に増加すると予想されます。現在、世界中で毎年約3億1,300万件の手術が行われており、創傷洗浄剤を含む効果的な創傷管理ソリューションのニーズも並行して高まっています。この需要は、術後ケアを必要とする外傷関連創傷の発生率の増加によってさらに高まっています。

創傷洗浄剤製品に対する消費者の認識と受容の高まり：個人の健康や衛生に対する意識の高まりと、創傷ケアに関する消費者教育の高まりが創傷洗浄剤製品の需要を牽引しています。急性創傷と慢性創傷の両方を積極的に管理するようになった消費者は、より早く治癒するための信頼できる解決策を求めています。ヘルスケア情報を入手しやすくなったことで、消費者は創傷洗浄剤を含む自宅での治療を選択するようになり、早期回復と感染予防に努めています。

市場成長を促進する創傷感染の増加：創傷感染症は、特に創傷に迅速に対処できない場合、ヘルスケアプロバイダーと患者の双方にとって安全上の重大な問題です。創傷治療において最も重要な初期段階は、感染部位の効果的な洗浄であり、これにより治癒プロセスが促進されます。世界の患者数の増加と火傷に関連した創傷感染の増加に伴い、創傷洗浄剤の需要は急性創傷と慢性創傷の両方の管理ニーズに対応するために拡大し続けています。

創傷治療専門クリニックの拡大が先端製品の需要を牽引複雑で慢性的な創傷の治療に重点を置く創傷専門クリニックの普及が、高度な創傷ケア製品の需要に拍車をかけています。こうしたクリニックは、糖尿病性潰瘍、褥瘡、その他の慢性創傷など治癒が困難な状態の患者を対象としているため、専門的な創傷ケアソリューションが必要となります。こうしたクリニックの増加に伴い、こうした患者集団の特定のニーズに合わせた高品質で高度な創傷洗浄剤へのニーズが高まっています。

市場の抑制要因

不十分な医療教育と意識：医療・福祉サービス提供者の経済的負担と患者のQoL（Quality of Life：生活の質）への影響は、創傷がもたらす大きな負担を浮き彫りにしています。欧州創傷管理協会（European Wound Management Association）によると、慢性創傷の管理は複雑であり、患者の予後に悪影響を及ぼす可能性があるため、創傷ケアに携わる者が必要な知識と専門性を持つことが極めて重要です。適切な教育を受けなければ、臨床家も患者もケアの最適化に苦慮し、コスト増と回復期間の長期化につながります。

不適切な償還方針：ヘルスケアシステム内に創傷洗浄剤に関する包括的な償還方針がないため、患者のアクセスが妨げられ、自己負担額が増加し、医療施設にさらなる負担がかかります。このような制限は医療提供者の選択肢を狭めるだけでなく、創傷ケア製品やサービスの技術革新も阻害します。さらに、診療報酬の不足は、必要な治療へのアクセスを制限することで、特に恵まれない人々に対する既存のヘルスケア格差を悪化させる可能性があります。

市場機会

新興経済圏での市場拡大：創傷洗浄剤に対する需要の高まりは、中国、インド、ブラジル、サウジアラビア、シンガポールなどの新興市場に大きな成長機会をもたらしています。これらの地域は、人口増加、アンメットニーズ、医療投資の増加などの要因によって大きな可能性を秘めています。特に中東では医療支出が増加しており、創傷洗浄剤メーカーにとって有利な条件が整っています。さらに、これらの市場では1人当たりの可処分所得の増加が見込まれており、創傷洗浄剤市場の拡大をさらに後押ししています。

製品/イノベーション戦略：世界の創傷洗浄剤市場は、製品、創傷タイプ、エンドユーザー、地域などのさまざまなカテゴリーに基づいて広範にセグメント化されています。これにより、読者はどのセグメントが最大のシェアを占め、どのセグメントが今後数年間で成長する可能性が高いかを明確に把握することができます。

当レポートでは、世界の創傷洗浄剤市場について調査し、市場の概要とともに、製品タイプ別、創傷別、エンドユーザー別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 世界の創傷洗浄剤の市場概要

• 市場見通し
• 業界展望
• 市場力学

第2章 世界の創傷洗浄剤市場（製品別）、100万米ドル、2023年～2035年

• 機会評価
• 成長シェアマトリックス
• 市販の洗剤
  • 業務用洗剤市場（エンドユーザー別）
  • 業務用洗剤市場（形態別）
• 生理食塩水
  • 生理食塩水創傷洗浄剤市場（エンドユーザー別）

第3章 世界の創傷洗浄剤市場（創傷別）、100万米ドル、2023年～2035年

• 機会評価
• 成長シェアマトリックス
• 慢性創傷
• 急性創傷

第4章 世界の創傷洗浄剤市場（エンドユーザー別）、100万米ドル、2023年～2035年

• 機会評価
• 成長シェアマトリックス
• 病院
• 専門クリニック
• 在宅ヘルスケア

第5章 世界の創傷洗浄剤市場（地域別）、100万米ドル、2023年～2035年

• 市場概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域
• 将来の可能性

第6章 世界の創傷洗浄剤市場-競合ベンチマーキングと企業プロファイル

• 競合ベンチマーキング
• 競合情勢
  • 各社の主要戦略と展開
  • 主な発展分析
  • 企業シェア分析/企業ポジション分析
• 企業プロファイル
  • 3M
  • ACTO GmbH
  • Argentum Medical, LLC
  • B.Braun S.E.
  • Bactiguard S.E.
  • Coloplast Group
  • Cardinal Health
  • Hollister Incorporated
  • Gentell, Inc.
  • Medline Industries
  • Molnlycke Health Care AB
  • Schulke & Mayr GmbH
  • Smith & Nephew
  • Sonoma Pharmaceuticals, Inc.
  • Sanara Medtech, Inc.
  • Urgo Medical

List of Figures

• Figure: Global Wound Cleanser Market, Dynamics Impact Analysis
• Figure: Global Wound Cleanser Market Coverage
• Figure: Global Wound Cleanser Market, Key Trends, Impact Analysis, 2023-2035
• Figure: Global Wound Cleanser Market, Patent Analysis, January 2022-March 2025
• Figure: Global Wound Cleanser Market, Competitive Landscape, January 2022-March 2025

List of Tables

• Table: Global Wound Cleanser Market Dynamics, Impact Analysis
• Table: Global Wound Cleanser Market, Regulatory Landscape
• Table: Global Wound Cleanser Market, (by Product), $Million, 2023-2035
• Table: Global Wound Cleanser Market, (by Wound), $Million, 2023-2035
• Table: Global Wound Cleanser Market, (by End User), $Million, 2023-2035

Market Introduction

The wound cleanser market is a rapidly growing sector within the healthcare industry, driven by increasing demand for effective wound care solutions. A wound cleanser is a specialized solution designed to clean and irrigate wounds, playing a crucial role in wound care management. The wound cleanser market includes a wide range of products formulated to remove debris, bacteria, and contaminants from wounds, ensuring optimal healing and infection prevention. These products are essential in preparing wounds for subsequent medical treatments, such as dressing applications, suturing, or other therapeutic interventions, making the wound cleanser market a vital component of modern healthcare.

Several factors are fueling the expansion of the wound cleanser market, including the rising prevalence of chronic diseases, which has led to an increased demand for wound care products. The growing number of surgical and trauma cases has further amplified the need for wound cleansing solutions, contributing to the overall growth of the wound cleanser market. Additionally, the increasing incidence of wound infections has underscored the importance of effective wound cleaning, thereby driving innovation and advancements in the wound cleanser market.

Another significant factor contributing to the expansion of the wound cleanser market is the increasing acceptance and adoption of advanced wound care products. The rise of specialized wound care clinics, along with advancements in medical technology, has led to greater awareness and utilization of wound cleansers in both clinical and homecare settings. The wound cleanser market continues to evolve, with manufacturers focusing on developing more efficient and innovative wound cleansing solutions that enhance healing outcomes and improve patient care. As demand for wound care products continues to rise, the wound cleanser market is poised for substantial growth in the coming years.

Impact Analysis

The wound cleanser market has made an impact in the following ways:

• Enhanced Wound Care Practices: The introduction of advanced wound cleansers has significantly improved wound care practices. These cleansers offer more effective solutions for cleaning wounds, minimizing infection risks, and accelerating the healing process.
• Reduced Infection Rates: Wound cleansers with antimicrobial properties have played a key role in lowering infection rates across healthcare settings. These products help prevent bacterial and pathogen growth in wounds, reducing the likelihood of complications.
• Accelerated Healing: Innovations in wound cleanser formulations have led to faster healing times. By efficiently removing debris and necrotic tissue, these products enable the body to focus on wound repair more effectively.
• Improved Patient Comfort: The development of gentle yet effective wound cleansers has enhanced patient comfort during treatment. Reduced pain and irritation during cleansing promote better adherence to prescribed care regimens.
• Cost Savings in Healthcare: By preventing complications and speeding up healing, wound cleansers contribute to reduced healthcare costs. Lower infection rates and shorter hospital stays generate financial savings for both patients and healthcare systems.
• Increased Accessibility: Advancements in wound cleanser technologies have expanded accessibility to a broader range of healthcare facilities, including hospitals, clinics, and home care environments. This ensures that patients receive high-quality wound care regardless of location.
• Integration of Cutting-Edge Technologies: The wound cleanser market has incorporated new technologies, such as smart wound cleansers that monitor healing progress or provide automated dosing. These innovations enable more personalized and effective wound care strategies.
• Ongoing Research and Development: The continued growth of the wound cleanser market has fostered increased investment in research and development. This includes the exploration of novel ingredients, formulations, and delivery methods to consistently enhance patient outcomes.

Market Segmentation:

Segmentation 1: by Product

• Commercial Cleanser
• Saline

Commercial Cleanser to Continue Dominating the Wound Cleanser Market (by Product)

Commercial wound cleansers are expected to dominate the wound care market due to their targeted formulations designed to effectively cleanse wounds and create an optimal healing environment. Available in various forms and tailored to meet specific wound care needs, these cleansers typically contain active ingredients that help remove debris, bacteria, and contaminants while promoting the healing process. Their specialized nature and effectiveness in managing different types of wounds make them a preferred choice for both healthcare providers and patients, driving their continued market dominance.

Saline wound cleansers are projected to grow at the fastest rate, primarily due to their simplicity, safety, and gentle action. Composed of a sterile solution of sodium chloride in purified water, saline closely mimics the body's natural fluids, making it an ideal, non-irritating option for wound irrigation and cleansing. Their widespread use in both clinical and homecare settings, combined with their low cost and minimal risk of complications, positions saline cleansers as a rapidly growing segment in the wound care market.

Segmentation 2: by Wound

• Chronic Wound
• Acute Wound

Chronic Wound to Register Maximum Growth Rate in the Market

Chronic wounds are complex, long-lasting injuries that result from disruptions in the natural healing process, often due to underlying conditions such as diabetes. These wounds, such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers, are difficult to heal and may persist for months or even years. Approximately 15-25% of individuals with diabetes are at risk of developing chronic wounds. Due to their persistent nature and the increasing prevalence of chronic conditions, chronic wounds are expected to dominate the wound cleanser market. The need for specialized wound care products that effectively address infection, promote healing, and manage complications will drive sustained demand in this segment.

Acute wounds, which heal predictably within 4-6 weeks, typically result from external trauma or injury. While these wounds follow a clear healing trajectory, the global incidence is on the rise, particularly in developed regions where accidents, surgeries, and sports-related injuries are common. As the number of acute wound cases increases, the demand for effective wound cleansers to manage these injuries will grow rapidly. The acute wound care segment is anticipated to grow at the fastest rate due to its short recovery time, high volume, and the growing awareness of proper wound management to prevent complications such as infections.

Segmentation 3: by End User

• Hospitals
• Specialty Clinics
• Homecare

Hospitals to Dominate the Global Wound Cleanser Market (by End User)

The hospital segment leads the wound cleanser market due to its substantial share in the treatment of both acute and chronic wounds. Hospitals are key drivers of demand, given their capacity to manage complex cases, including surgical wounds, burns, and trauma-related injuries, all of which require specialized wound cleansing solutions. Additionally, hospitals are equipped with advanced medical resources, making them a critical focal point for wound care.

The homecare segment is the fastest-growing in the market. This growth is fueled by the increasing preference for at-home wound management, particularly for chronic conditions such as diabetic ulcers and pressure sores. Rising consumer awareness of self-care, combined with the convenience and availability of advanced over-the-counter wound care products, is driving the rapid expansion of the homecare segment in the wound cleanser market.

Segmentation 4: by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Portugal
  • Netherlands
  • Ireland
  • Belgium
  • Switzerland
  • Norway
  • Denmark
  • Sweden
  • Finland
  • Czech Republic
  • Russian Federation
  • Poland
  • Austria
  • Romania
  • Slovakia
  • Greece
  • Turkey
  • Ukraine
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
  • Malaysia
  • Rest-of-Asia-Pacific
• Latin America
  • Brazil
  • Argentina
  • Chile
  • Colombia
  • Rest-of-Latin America
• Rest-of-the-World

North America held the largest market share in 2024 due to its advanced healthcare infrastructure, strong economic support, and rising prevalence of chronic conditions such as diabetes and obesity, which contribute to an increased incidence of chronic wounds. In the U.S., the demand for wound cleansers is bolstered by leading manufacturers such as 3M, which offers products such as the 3M Tegaderm Wound Cleanser, and Medline, with their Medline Remedy Phytoplex Skin & Wound Cleanser. These products are widely used in hospitals and homecare settings for their effectiveness in preventing infections and promoting faster healing. Additionally, the aging population in North America drives the need for wound care products, with over 6 million Americans suffering from chronic wounds, particularly pressure ulcers and diabetic foot ulcers. This demographic shift is supported by comprehensive healthcare policies that ensure broad access to wound care products, fostering growth in the wound cleanser market.

China led the Asia-Pacific wound cleanser market in 2024. Key drivers of this growth include the increasing demand for wound recovery products, a rising prevalence of chronic wounds, and a growing number of surgical procedures throughout the region. A notable factor contributing to this demand is the high prevalence of diabetes in China, which heightens the need for wound care solutions to address delayed healing in diabetic patients. Foot ulcers, a common and debilitating complication among diabetic individuals, often lead to serious outcomes such as leg amputation. According to the International Diabetes Federation (IDF), China had 140.9 million cases of diabetes in 2021, representing 10.6% of the population. This number is projected to rise to 164.06 million by 2030, with an estimated 72.83 million undiagnosed cases in 2021. The high incidence of diabetes directly correlates with increased demand for diabetic foot care management and wound care products, particularly in the context of diabetic foot ulcers.

Recent Developments in the Wound Cleanser Market

• In April 2023, Sanara MedTech Inc. announced receiving 510(k) clearance for its Biasurge advanced surgical solution, a patented formulation utilizing Biakos technology. Biasurge is designed for mechanical cleansing and the removal of debris, including microorganisms, from wounds.
• In January 2023, Sonoma Pharmaceuticals, Inc. revealed a distribution and pricing agreement for its Microcyn Rx products, granted by the Defense Logistics Agency (DLA). This agreement enables the distribution of Microcyn Rx products through the DLA's network, marking a key milestone for the company.
• In November 2021, Sonoma Pharmaceuticals, Inc. and Dyamed Biotech Pte Ltd. expanded their long-term partnership, focusing on the Singapore, Malaysia, Indonesia, and Thailand markets. The collaboration aims to leverage Sonoma's Microcyn technology, benefiting both patients and healthcare providers.
• In March 2021, Sonoma Pharmaceuticals, Inc. entered into an agreement with EMC Pharma, LLC, to oversee, promote, and distribute Sonoma's prescription dermatology and eye care products based on HOCl in the U.S. The agreement is set for an initial term of five years, with potential for extension.
• In November 2022, InfuSystem Holdings, Inc. and Sanara MedTech Inc. formed a partnership for SI Wound Care, LLC, aimed at delivering a comprehensive wound care solution that enhances patient outcomes, reduces care costs, and boosts satisfaction for both patients and providers. The partnership enables InfuSystem to introduce innovative products, including Cork Medical LLC's negative pressure wound therapy devices and Sanara's advanced wound care solutions, to new customers.
• In June 2023, Armis Biopharma's VeriCyn Wound Wash medical device received 510(k) clearance from the FDA, allowing it to be used for cleansing wounds of debris.
• In April 2023, Convatec acquired technology from U.K.-based 30 Technology, sparking speculation about how and when this technology will be integrated into Convatec's existing product portfolio.
• In February 2023, Shore Capital Partners sold Argentum Medical to BioDerm.
• In May 2023, NovaBay Pharmaceuticals, Inc. announced that China Pioneer Pharma Holdings, Limited had placed a $1 million order for NovaBay's NeutroPhase Skin and Wound Cleanser. NovaBay completed the order fulfillment and expects to recognize the associated revenue in Q2 2023.
• In May 2019, Smith & Nephew acquired Osiris Therapeutics, Inc., a company specializing in the development and promotion of regenerative medicine products for wound care, orthopedics, and sports medicine.

Demand - Drivers and Limitations

Market Demand Drivers:

Rising Prevalence of Chronic Diseases Driving Increased Utilization of Wound Cleansers: The global rise in chronic diseases, now responsible for 63% of all global deaths, has significantly contributed to the increase in wound infections. In the U.S., chronic conditions affect over 133 million individuals-accounting for over 40% of the population. This surge in chronic disease prevalence is directly influencing the demand for wound cleansers, as managing chronic wounds becomes critical in improving patient outcomes.

Surge in Surgical and Trauma Cases Amplifying Demand for Wound Cleansers: With improved healthcare accessibility and a rapidly aging population, the number of surgical procedures performed annually is expected to rise substantially. Currently, approximately 313 million surgeries are conducted globally each year, creating a parallel increase in the need for effective wound management solutions, including wound cleansers. This demand is further amplified by the higher incidence of trauma-related wounds requiring post-operative care.

Growing Consumer Awareness and Acceptance of Wound Cleanser Products: Heightened awareness of personal health and hygiene, coupled with increasing consumer education on wound care, is driving the demand for wound cleanser products. As individuals become more proactive in managing both acute and chronic wounds, they seek reliable solutions for faster healing. With greater access to healthcare information, consumers are increasingly opting for at-home treatments, including wound cleansers, to ensure quicker recovery and prevent infections.

Escalating Incidence of Wound Infections Fostering Market Growth: Wound infections remain a significant safety concern for both healthcare providers and patients, particularly when wounds are not promptly addressed. The initial and most critical step in wound care is the effective cleansing of infected areas, which accelerates the healing process. With the rise in global patient populations and a growing number of burn-related wound infections, the demand for wound cleansers continues to expand to meet the needs of both acute and chronic wound management.

Expansion of Specialty Wound Care Clinics Driving Demand for Advanced Products: The increasing prevalence of specialty wound care clinics, which focus on treating complex and chronic wounds, is fueling the demand for advanced wound care products. These clinics cater to patients with difficult-to-heal conditions such as diabetic ulcers, pressure ulcers, and other chronic wounds, necessitating specialized wound care solutions. As these clinics proliferate, the need for high-quality, advanced wound cleansers tailored to the specific needs of these patient populations grows.

Market Restraints:

Insufficient Medical Education and Awareness: The financial strain on health and social care providers, coupled with the impact on patient quality of life (QoL), highlights the significant burden posed by wounds. According to the European Wound Management Association, it is crucial that those involved in wound care possess the necessary knowledge and expertise, as managing chronic wounds is complex and can adversely affect patient outcomes. Without proper education, both clinicians and patients may struggle to optimize care, leading to increased costs and prolonged recovery periods.

Inadequate Reimbursement Policies: The absence of comprehensive reimbursement policies for wound cleansers within healthcare systems creates barriers to patient access, increases out-of-pocket expenses, and places additional strain on healthcare facilities. This limitation not only reduces provider options but also stifles innovation in wound care products and services. Furthermore, the lack of reimbursement can exacerbate existing healthcare disparities, particularly for underserved populations, by limiting access to necessary treatment.

Market Opportunities:

Market Expansion in Emerging Economies: The growing demand for wound cleansers offers substantial growth opportunities in emerging markets, including China, India, Brazil, Saudi Arabia, and Singapore. These regions present significant potential driven by factors such as population growth, unmet healthcare needs, and increasing healthcare investments. In particular, the rising healthcare expenditure in the Middle East creates favorable conditions for wound cleanser manufacturers. Additionally, the expected increase in per capita disposable income in these markets further propels the expansion of the wound cleanser market.

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The global wound cleanser market has been extensively segmented based on various categories, such as products, wound types, end users, and regions. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• Detailed secondary research was performed to ensure maximum coverage of manufacturers/suppliers operational in a country.
• Exact revenue information, up to a certain extent, was extracted for each company from secondary sources and databases. The revenues specific to the product/type/application were then estimated for each market player based on fact-based proxy indicators as well as primary inputs.
• The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of wound cleanser products.
• The market contribution of the wound cleanser product anticipated to be launched in the future has been calculated based on historical analysis. This analysis has been supported by proxy factors such as the innovation scale of the companies, the status of funding, collaborations, customer base, and patent scenario.
• The scope of availability of wound cleanser products in a particular region has been assessed based on a comprehensive analysis of companies' prospects, the regional end-user perception, and other factors impacting the launch of wound cleanser products in that region.
• The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2021-FY2023. The market size has been estimated for FY2024 and projected for the period FY2025-FY2035.
• Revenues of the companies have been referenced from their annual reports for FY2021, FY2022, and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, product approval status, market collaborations, and operational history.
• Regional distribution of the market revenue has been estimated based on the companies in each region and the adoption rate of wound cleanser products. All the numbers have been adjusted to a single digit after the decimal for better presentation in the report. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. The CAGR has been calculated for the period 2025-2035.
• The market has been mapped based on the available wound cleanser products. All the key companies with significant offerings in this field have been considered and profiled in this report.
• Market strategies and developments of key players have been considered for the calculation of the potential of the market in the forecast period.

Primary Research:

The primary sources involve industry experts in the wound cleanser market, including the market players offering wound cleanser products and end users. Resources such as COOs, vice presidents, product managers, directors, territory managers, and business development have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

• Validation and triangulation of all the numbers and graphs
• Validation of the report's segmentation and key qualitative findings for wound cleansers
• Understanding the competitive landscape and business model
• Current and proposed production values of a product by market players
• Validation of the numbers of the different segments of the market in focus
• Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• National Center for Biotechnology Information (NCBI), PubMed, Science Direct, American Heart Association (AHA), Mayo Clinic, International Diabetes Federation, World Health Organization (WHO)
• Annual reports, SEC filings, and investor presentations of the leading market players
• Company websites and detailed study of their portfolios
• Gold standard magazines, journals, whitepapers, press releases, and news articles
• Databases

The key data points taken from the secondary sources include:

• Segmentation and percentage share estimates
• company and country understanding, and data for market value estimation.
• Key industry/market trends
• Developments among top players
• qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names in this market are:

• ACTO GmbH
• Urgo Medical
• Argentum Medical, LLC
• Schulke & Mayr
• Gentell, Inc.
• Hollister Incorporated
• Smith & Nephew
• Sonoma Pharmaceuticals, Inc
• B. Braun S.E.
• Molnlycke Health Care AB
• Coloplast Corp
• Medline Industries, LP
• Cardinal Health, Inc.
• Sanara Medtech, Inc.
• Bactiguard AB

Table of Contents

Executive Summary

Scope of Study

Research Methodology

1. Global Wound Cleanser Market Overview

• 1.1 Market Outlook
  • 1.1.1 Definitions
  • 1.1.2 Inclusion and Exclusion Criteria
  • 1.1.3 Market Size, 2024-2035 ($Million)
• 1.2 Industry Outlook
  • 1.2.1 Introduction
  • 1.2.2 Market Overview and Ecosystem
  • 1.2.3 Key Trends
  • 1.2.4 Opportunity Assessment
  • 1.2.5 Pricing Analysis
  • 1.2.6 Supply Chain Analysis
• 1.3 Market Dynamics
  • 1.3.1 Market Opportunities and Trends
  • 1.3.2 Market Drivers
    • 1.3.2.1 Impact Analysis
  • 1.3.3 Market Restraints
    • 1.3.3.1 Impact Analysis

2. Global Wound Cleanser Market (By Product), $Million, 2023-2035

• 2.1 Opportunity Assessment
• 2.2 Growth-Share Matrix
• 2.3 Commercial Cleanser
  • 2.3.1 Commercial Cleanser Market (by End User)
  • 2.3.2 Commercial Cleanser Market (by Format Type)
• 2.4 Saline
  • 2.4.1 Saline Wound Cleanser Market (by End User)

3. Global Wound Cleanser Market (By Wound), $Million, 2023-2035

• 3.1 Opportunity Assessment
• 3.2 Growth-Share Matrix
• 3.3 Chronic Wound
• 3.4 Acute Wound

4. Global Wound Cleanser Market (By End User), $Million, 2023-2035

• 4.1 Opportunity Assessment
• 4.2 Growth-Share Matrix
• 4.3 Hospitals
• 4.4 Specialty Clinics
• 4.5 Home Healthcare

5. Global Wound Cleanser Market (By Region), $Million, 2023-2035

• 5.1 Market Overview
  • 5.1.1 North America
  • 5.1.2 Legal Framework and Regulatory Requirements
  • 5.1.3 Key Findings and Opportunity Assessment
  • 5.1.4 Market Dynamics
    • 5.1.4.1 Impact Analysis
  • 5.1.5 Market Sizing and Forecast
    • 5.1.5.1 North America Wound Cleanser Market (by Product)
    • 5.1.5.2 North America Wound Cleanser Market (by Country)
    • 5.1.5.3 Market Dynamics and Market Size Forecast
      • 5.1.5.3.1 U.S.
      • 5.1.5.3.2 Canada
  • 5.1.6 Europe
  • 5.1.7 Legal Framework and Regulatory Requirements
  • 5.1.8 Key Findings and Opportunity Assessment
  • 5.1.9 Market Dynamics
    • 5.1.9.1 Impact Analysis
  • 5.1.10 Market Sizing and Forecast
    • 5.1.10.1 Europe Wound Cleanser Market (by Product)
    • 5.1.10.2 Europe Wound Cleanser Market (by Country)
    • 5.1.10.3 Market Dynamics and Market Size Forecast
      • 5.1.10.3.1 U.K.
      • 5.1.10.3.2 Germany
      • 5.1.10.3.3 France
      • 5.1.10.3.4 Italy
      • 5.1.10.3.5 Spain
      • 5.1.10.3.6 Portugal
      • 5.1.10.3.7 Ireland
      • 5.1.10.3.8 Switzerland
      • 5.1.10.3.9 Norway
      • 5.1.10.3.10 Belgium
      • 5.1.10.3.11 Denmark
      • 5.1.10.3.12 Netherlands
      • 5.1.10.3.13 Sweden
      • 5.1.10.3.14 Finland
      • 5.1.10.3.15 Czech Republic
      • 5.1.10.3.16 Russian Federation
      • 5.1.10.3.17 Poland
      • 5.1.10.3.18 Austria
      • 5.1.10.3.19 Romania
      • 5.1.10.3.20 Slovakia
      • 5.1.10.3.21 Greece
      • 5.1.10.3.22 Turkey
      • 5.1.10.3.23 Ukraine
  • 5.1.11 Asia Pacific
  • 5.1.12 Legal Framework and Regulatory Requirements
  • 5.1.13 Key Findings and Opportunity Assessment
  • 5.1.14 Market Dynamics
    • 5.1.14.1 Impact Analysis
  • 5.1.15 Market Sizing and Forecast
    • 5.1.15.1 Asia-Pacific Wound Cleanser Market (by Product)
    • 5.1.15.2 Asia-Pacific Wound Cleanser Market (by Country)
    • 5.1.15.3 Market Dynamics and Market Size Forecast
      • 5.1.15.3.1 Japan
      • 5.1.15.3.2 China
      • 5.1.15.3.3 India
      • 5.1.15.3.4 Australia
      • 5.1.15.3.5 Thailand
      • 5.1.15.3.6 Malaysia
      • 5.1.15.3.7 South Korea
      • 5.1.15.3.8 Rest-of-Asia Pacific
  • 5.1.16 Latin America
  • 5.1.17 Legal Framework and Regulatory Requirements
  • 5.1.18 Key Findings and Opportunity Assessment
  • 5.1.19 Market Dynamics
    • 5.1.19.1 Impact Analysis
  • 5.1.20 Market Sizing and Forecast
    • 5.1.20.1 Latin America Wound Cleanser Market (by Product)
    • 5.1.20.2 Latin America Wound Cleanser Market (by Country)
    • 5.1.20.3 Market Dynamics and Market Size Forecast
      • 5.1.20.3.1 Brazil
      • 5.1.20.3.2 Argentina
      • 5.1.20.3.3 Chile
      • 5.1.20.3.4 Colombia
      • 5.1.20.3.5 Rest-of-Latin America
  • 5.1.21 Rest-of-the-World
  • 5.1.22 Key Findings and Opportunity Assessment
  • 5.1.23 Market Dynamics
    • 5.1.23.1 Impact Analysis
  • 5.1.24 Market Sizing and Forecast
    • 5.1.24.1 Rest-of-the-World Wound Cleanser Market (by Product)
• 5.2 Future Potential

6. Global Wound Cleanser Market- Competitive Benchmarking and Company Profiles

• 6.1 Competitive Benchmarking
• 6.2 Competitive Landscape
  • 6.2.1 Key Strategies and Developments by Company
    • 6.2.1.1 Funding Activities
    • 6.2.1.2 Merger and Acquisition
    • 6.2.1.3 Regulatory Approvals
    • 6.2.1.4 Partnerships, Collaboration, and Business Expansion
  • 6.2.2 Key Developments Analysis
  • 6.2.3 Company Share Analysis/ Company Position Analysis
• 6.3 Company Profiles
  • 6.3.1 3M
    • 6.3.1.1 Company Overview
    • 6.3.1.2 Product Portfolio
    • 6.3.1.3 Target Customers/End Users
    • 6.3.1.4 Analyst View
  • 6.3.2 ACTO GmbH
    • 6.3.2.1 Company Overview
    • 6.3.2.2 Product Portfolio
    • 6.3.2.3 Target Customers/End Users
    • 6.3.2.4 Analyst View
  • 6.3.3 Argentum Medical, LLC
    • 6.3.3.1 Company Overview
    • 6.3.3.2 Product Portfolio
    • 6.3.3.3 Target Customers/End Users
    • 6.3.3.4 Analyst View
  • 6.3.4 B.Braun S.E.
    • 6.3.4.1 Company Overview
    • 6.3.4.2 Product Portfolio
    • 6.3.4.3 Target Customers/End Users
    • 6.3.4.4 Analyst View
  • 6.3.5 Bactiguard S.E.
    • 6.3.5.1 Company Overview
    • 6.3.5.2 Product Portfolio
    • 6.3.5.3 Target Customers/End Users
    • 6.3.5.4 Analyst View
  • 6.3.6 Coloplast Group
    • 6.3.6.1 Company Overview
    • 6.3.6.2 Product Portfolio
    • 6.3.6.3 Target Customers/End Users
    • 6.3.6.4 Analyst View
  • 6.3.7 Cardinal Health
    • 6.3.7.1 Company Overview
    • 6.3.7.2 Product Portfolio
    • 6.3.7.3 Target Customers/End Users
    • 6.3.7.4 Analyst View
  • 6.3.8 Hollister Incorporated
    • 6.3.8.1 Company Overview
    • 6.3.8.2 Product Portfolio
    • 6.3.8.3 Target Customers/End Users
    • 6.3.8.4 Analyst View
  • 6.3.9 Gentell, Inc.
    • 6.3.9.1 Company Overview
    • 6.3.9.2 Product Portfolio
    • 6.3.9.3 Target Customers/End Users
    • 6.3.9.4 Analyst View
  • 6.3.10 Medline Industries
    • 6.3.10.1 Company Overview
    • 6.3.10.2 Product Portfolio
    • 6.3.10.3 Target Customers/End Users
    • 6.3.10.4 Analyst View
  • 6.3.11 Molnlycke Health Care AB
    • 6.3.11.1 Company Overview
    • 6.3.11.2 Product Portfolio
    • 6.3.11.3 Target Customers/End Users
    • 6.3.11.4 Analyst View
  • 6.3.12 Schulke & Mayr GmbH
    • 6.3.12.1 Company Overview
    • 6.3.12.2 Product Portfolio
    • 6.3.12.3 Target Customers/End Users
    • 6.3.12.4 Analyst View
  • 6.3.13 Smith & Nephew
    • 6.3.13.1 Company Overview
    • 6.3.13.2 Product Portfolio
    • 6.3.13.3 Target Customers/End Users
    • 6.3.13.4 Analyst View
  • 6.3.14 Sonoma Pharmaceuticals, Inc.
    • 6.3.14.1 Company Overview
    • 6.3.14.2 Product Portfolio
    • 6.3.14.3 Target Customers/End Users
    • 6.3.14.4 Analyst View
  • 6.3.15 Sanara Medtech, Inc.
    • 6.3.15.1 Company Overview
    • 6.3.15.2 Product Portfolio
    • 6.3.15.3 Target Customers/End Users
    • 6.3.15.4 Analyst View
  • 6.3.16 Urgo Medical
    • 6.3.16.1 Company Overview
    • 6.3.16.2 Product Portfolio
    • 6.3.16.3 Target Customers/End Users
    • 6.3.16.4 Analyst View